189 results on '"GADLER, FREDRIK"'
Search Results
2. Endocardial pacing compared to epicardial left ventricle pacing and right ventricle pacing: A single-center long-term experience in a pediatric population
3. Incidence and Predictors of Out-of-Hospital Cardiac Arrest Within 90 Days After Myocardial Infarction
4. Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy
5. Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population
6. Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County
7. Erratum. Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population. Diabetes Care 2020;44:2853–2858
8. Women with atrial fibrillation undergoing pulmonary vein isolation are more symptomatic but improve more in health-related quality of life and symptom burden than men
9. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy:Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)
10. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
11. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry
12. Awareness of indications for device therapy among a broad range of physicians: a survey study
13. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume
14. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades
15. A Randomized Comparison of Triple-Site Versus Dual-Site Ventricular Stimulation in Patients With Congestive Heart Failure
16. Positron emission tomography (O-15-water, C-11-acetate, C-11-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy
17. Rate, time course, and predictors of implantable cardioverter defibrillator infections: an analysis from the SIMPLE trial
18. Cardiovascular Imaging Applications in Clinical Management of Patients Treated with Cardiac Resynchronization Therapy
19. Women have better long-term prognosis than men after cardiac resynchronization therapy
20. The European CRT Survey: 1 year (9–15 months) follow-up results
21. Paroxysmal Regular Supraventricular Tachycardia: The Diagnostic Accuracy of the Transesophageal Ventriculo-Atrial Interval
22. Effects of cardiac resynchronization therapy on myocardial contractile reserve during exercise
23. Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population
24. Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial
25. Pacing therapy in children with isolated complete atrioventricular block: a retrospective study of pacing system survival and pacing-related complications in a national cohort—Authors’ reply
26. Rapid effects of air pollution on ventricular arrhythmias
27. Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods
28. Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study
29. Biventricular vs. left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study
30. Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation
31. Pacing therapy in children with isolated complete atrioventricular block: a retrospective study of pacing system survival and pacing-related complications in a national cohort
32. TCT-532 Impact of New Pacemaker in Patients Undergoing TAVR: A Report From the National SWENTRY and Swedish ICD and Pacemaker Registries
33. Hypertrofisk kardiomyopati vanligaste ärftliga hjärtsjukdomen: Sjukdomsförloppet är ofta godartat - Men risken för plötslig död i arytmi är välkänd : [Management of hypertrophic cardiomyopathy - The most common inherited heart disease]
34. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA
35. Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions
36. Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure
37. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
38. Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy
39. Causes of death and mortality in hypertrophic cardiomyopathy patients with implantable defibrillators in Sweden
40. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators
41. Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
42. Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
43. Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial
44. 96-60: Long-term single center experience of an active fixation LV lead
45. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators
46. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database
47. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden : Inappropriate Shocks and Complications Requiring Surgery
48. Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.
49. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence
50. Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.